Oligonucleotide and use thereof

Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Carbohydrate doai

Reexamination Certificate

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

C536S023100

Reexamination Certificate

active

08030289

ABSTRACT:
An oligonucleotide with a nucleotide sequence of 5′-cctcctcctcctcctcctcctcct-3′ (SEQ ID NO: 1) inhibits proliferation of human PBMC activated by TLR9 agonist and interferon production from human PBMC induced by TLR9 agonist, HSV-1, flu virus and serum from SLE patients, and rescues the mice from cytokine-mediated lethal shock. This oligonucleotide can be used as a remedy for the treatment of systemic lupus erythematosus (SLE), sepsis, multiple organ dysfunction syndromes and other immune-mediated disorders.

REFERENCES:
patent: 2007/0238678 (2007-10-01), Barrat et al.
patent: WO 2006/028742 (2006-03-01), None
Sun et al. A human microsatellite DNA-mimicking oligodeoxynucleotide with CCT repeats negatively regulates TLR7/9-mediated innate immune responses via selected TLR pathways. Clin. Immunology 134:262-276, 2010.
Barrat et al. Treatment of lupus-prone mice with a dual inhibitor of TLR7 and TLR9 leads to reduction of autoantibody production and amelioration of disease symptoms. Eur. J. Immunol. 37:3582-3586, 2007.
Shirota et al. Suppressive oligodeoxynucleotides protect mice from lethal endotoxic shock. J. Immunology 174:4579-4583, 2005.
Dong et al. Suppressive oligodeoxynucleotides delay the onset of glomerulonephritis and prolong survival in lupus-prone NZB x NZW mice. Arthritis & Rheumatism 52:651-658, 2005.
Vallin, et al., Anti-Double-Stranded DNA Antibodies and Immunostimulatory Plasmid DNA in Combination Mimic the Endogenous IFN-α Inducer in Systemic Lupus Erythematosus,The Journal of Immunology1999, 163:6306-6313.
Writing Committee of the World Health Organization, Avian Influenza A (H5N1) Infection in Humans,New Eng. J. Med., 355;13 pp. 1374-1385 (2005).
DeWit, et al., Blood plasmacytoid dendritic cell response to CpG oligodeoxynucleotides are impaired inhuman newborns,Blood, 103:1030-1032 (2004).
Leadbetter et al., Chromatin-IgG complexes activate B cells by dual engagement of IgM and toll-like receptors,Nature, vol. 416:603-607 (2002).
Kumar et al., CpG Oligodeoxynucleotide and Montanide ISA 51 Adjuvant Combination Enhanced the Protective Efficacy of a Subunit Malaria Vaccine,Infection and Immunity, vol. 72, No. 2, pp. 949-957 (2004).
Slifka et al., Clinical implications of dysregulated cytokine production,J. Mol. Med., 78:74-80 (2000).
Liew et al., Negative regulation of toll-like receptor-mediated immune responses,Nature Reviews, vol. 5, pp. 466-458 (2005).
Hochrein et al., Herpes simplex virus type-1 induces IFN-α production via toll-like receptor 9-dependent and-independent pathways,PNAS, vol. 101 pp. 11416-11421 (2004).
Duramad et al., Inhibitors of TLR-9 Act on Multiple Cell Subsets in Mouse and Man in Vitro and Prevent Death in Vivo from Systemic Inflammation,The Journal of Immunology, 2005, 174:5193-5200.
Barrat et al., Nucleic acids of mammalian origin can act as endogenous ligands for toll-like receptors and may promote systemic lupus erythematosus,JEM, vol. 202, No. 8, (2005) 1131-1139.
Vallin et al., Patients with systemic lupus erythematosus (SLE) have a circulating inducer of interferon-alpha (IFN-α) production acting on leucocytes resembling immature dendritic cells,Clin Exp Immunol, 1999, 111:196-202.
Espat et al., PEG-BP-30 Monotherapy attenuates the cytokine-mediated inflammatory cascade in baboonEscherichia coliseptic shock,Journal of Surgical Research, 59, 153-158 (1995).
Ito et al., Specialization, kinetics, and repertoire of type 1 interferon responses by human plasmacytoid predendritic cells,Blood, (2006) vol. 107, No. 6.
Arthur M. Krieg, Therapeutic potential of toll-like receptor 9 activation, Nature Reviews, vol. 5, pp. 471-484 (2006).
Christensen et al., Toll-like receptor 7 and TLR9 dictate autoantibody specificity and have opposing inflammatory and regulatory roles in a murine model of lupus,Immunity, vol. 25:417-428 (2006).
Boulé et al., Toll-like receptor 9-dependent and -independent dendritic cell activation by chromatin-immunoglobulin G complexes,J. Exp. Med., vol. 199, No. 12, (2004) pp. 1631-1640.
Marshall et al.,Toxoplasma gondiiTriggers Granulocyte-Dependent Cytokine-Mediated Lethal Shock in D-Galactosamine-Sensitized Mice,Infection and Immunity, vol. 66, No. 4 (1998) p. 1325-1333.
Hashem et al, Hybrid Oligomer Duplexes Formed with Phosphorothioate DNAs: CD Spectra and Melting Temperatures of S-DNA-RNA Hybrids are Sequence-Dependent but Consistent with Similar Heteronomous Conformations,Biochemistry37, 61-72 (1998). XP-002970373.
Hung, et al., Evidence from CD spectra that d(purine) r(pyrimidine) and r(purine) d(pyrimidine) hybrids are in different structural classes,Nucleic Acids Research, vol. 22, No. 20 (1994). XP-002500581.
Ashman, et al., Sequence requirements for oligodeoxyribonucleotide inhibitory activity,International Immunology, vol. 17, No. 4, pp. 411-420. XP-002380605 •, 2005.
Mackay et al., Autoimmune Diseases,The New England Journal of Medicine, vol. 345 No. 5, pp. 340-350 (2001).
Dennis M. Klinman, Immunotherapeutic uses of CpG oligodeoxynucleotides,Nature Reviews, vol. 4, pp. 1-10 (2004).
Marcus E. Peter, ROS Eliminate Danger,Immunity29, pp. 1-2 (2008).
Wang et al., The cytokine storm and factors determining the sequence and severity of organ dysfunction in multiple organ dysfunction syndrome,American Journal of Emergency Medicine(2008) 26, 711-715.
Wellmann et al., The evolution of human anti-double-stranded DNA autoantibodies,PNAS, (2005) vol. 102, No. 26, pp. 9258-9263.
Wang et al., Toll-like receptor-mediated activation of neutrophils by influenza A virus,Blood, Published online Jun. 10, 2008, pp. 130.

LandOfFree

Say what you really think

Search LandOfFree.com for the USA inventors and patents. Rate them and share your experience with other people.

Rating

Oligonucleotide and use thereof does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Oligonucleotide and use thereof, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Oligonucleotide and use thereof will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFUS-PAI-O-4297483

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.